Ellomay Capital Reports Results for the Three and Six Months Ended June 30, 2021

TEL AVIV, Israel, Sept. 30, 2021 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported its unaudited financial results for the three and six month periods ended June 30, 2021.

Financial Highlights

  • Revenues were approximately €19.5 million for the six months ended June 30, 2021, compared to approximately €4.2 million for the six months ended June 30, 2020. The increase in revenues is mainly attributable to the achievement of PAC (preliminary acceptance certificate) of the photovoltaic plant held by Talasol Solar S.L. (the "Talasol PV Plant") on January 27, 2021, upon which the Company commenced recognition of revenues. The increase is also attributable to the acquisition of the Groen Gas Gelderland B.V. biogas facility (the "Gelderland Biogas Plant"), in December 2020 and to improved operational efficiency at the Company's biogas plants in the Netherlands.
  • Operating expenses were approximately €7.5 million for the six months ended June 30, 2021, compared to approximately €2.1 million for the six months ended June 30, 2020. The increase in operating expenses is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021 and the acquisition of the Gelderland Biogas Plant in December 2020. Depreciation expenses were approximately €7.1 million for the six months ended June 30, 2021, compared to approximately €1.4 million for the six months ended June 30, 2020.
  • Project development costs were approximately €1.1 million for the six months ended June 30, 2021, compared to approximately €2.3 million for the six months ended June 30, 2020. The decrease in project development costs is mainly due to capitalization of expenses in connection with the project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.
  • General and administrative expenses were approximately €2.6 million for the six months ended June 30, 2021, compared to approximately €2.2 million for the six months ended June 30, 2020. The increase is mostly due to increased D&O liability insurance costs and to the Talasol PV Plant's expenses following the achievement of PAC of the Talasol PV Plant on January 27, 2021.
  • Company's share of loss of equity accounted investee, after elimination of intercompany transactions, was approximately €0.8 million for the six months ended June 30, 2021, compared to a profit of approximately €0.9 million in the six months ended June 30, 2020. The decrease in the Company's share of profit of equity accounted investee is mainly attributable to the decrease in revenues of Dorad Energy Ltd. ("Dorad") and higher financing expenses incurred by Dorad for the period as a result of the CPI indexation of loans from banks.
  • Financing expenses, net was approximately €6.2 million for the six months ended June 30, 2021, compared to approximately €1.1 million for the six months ended June 30, 2020. The increase in financing expenses, net, was mainly due to €0.8 million of expenses in connection with the early repayment of the Company's Series B Debentures and financing expenses in connection with the Talasol PV Plant previously capitalized to fixed assets that are recognized in profit and loss starting from PAC, including approximately €1.1 million of interest on bank loans, €0.6 million of swap related payments, €0.7 million of expenses in connection with the Talasol PV Plant project finance and approximately €0.9 million of interest accrued on shareholder loans granted by the minority shareholders of Talasol.
  • Taxes on income was approximately €0.1 million for the six months ended June 30, 2021 and 2020.
  • Net loss was approximately €5.8 million for the six months ended June 30, 2021, compared to approximately €4.3 million for the six months ended June 30, 2020.
  • Total other comprehensive loss was approximately €4.7 million for the six months ended June 30, 2021, compared to a loss of approximately €9.2 million for the six months ended June 30, 2020. The change was mainly due to changes in fair value of cash flow hedges and from foreign currency translation differences on NIS denominated operations, as a result of fluctuations in the euro/NIS exchange rates.
  • Total comprehensive loss was approximately €10.5 million for the six months ended June 30, 2021, compared to approximately €13.5 million for the six months ended June 30, 2020.
  • EBITDA was approximately €7.5 million for the six months ended June 30, 2021, compared to negative EBITDA of approximately €(1.6) million for the six months ended June 30, 2020.
  • Net cash provided by operating activities was approximately €6.4 million for the six months ended June 30, 2021, compared to net cash used in operating activities of approximately €1.9 million for the six months ended June 30, 2020. The increase in net cash from operating activities is mainly attributable to the achievement of PAC of the Talasol PV Plant on January 27, 2021, upon which the Company commenced recognition of revenues and expenses.
  • As of September 1, 2021, the Company held approximately €72.5 million in cash and cash equivalents and approximately €7.2 million in restricted short-term and long-term cash.

Second Quarter 2021 CEO Review

Ran Fridrich, CEO and a board member of the Company, provided the following CEO review:

The results of the first half reflect the continuation of the Company's projected business plan and are in line with the Company's forecasts. The main efforts of the Company are in three levels: (a) operation and improvement of the existing asset portfolio, (b) supervision and management of the construction of the various projects (pumped storage in the Manara Cliff, Israel and a 28 MW photovoltaic plant in Spain) and (c) development of new projects, mainly photovoltaic projects in Italy, Spain and Israel (in the aggregate of approximately 450 MW in advanced stages and approximately 800 MW in the preliminary stages).

Operation of the Existing Asset Portfolio

Revenues in the photovoltaic segments exceeded the Company's forecasts. The revenues of the Spanish portfolio under government subsidy (approximately 7.9 MW) were higher by 6.6% higher than the forecast, the revenues of the Talasol PV Plant (including income derived during the period before the achievement of PAC) were 3% higher than the forecast and the revenues of the Talmei Yosef PV Plant (under the fixed asset model) were 4% higher than the forecast.

Revenues of the biogas segment in the Netherlands were 4% lower than the forecast mainly due to the subsidy method used in the Netherlands, which is paid based on the average price in the year preceding the year of payment. The low gas prices in 2020 caused a deduction of approximately €1 million from revenues in 2021. In light of gas prices in 2021, the Company expects that in 2022 the subsidy will increase and will be paid in accordance with the forecasts. Despite the impact on the subsidy in the first half of 2021, the Company estimates that the revenue gap will decrease during the remainder of 2021.

The Dorad Power Station contributed a loss of €0.7 million in the first half of 2021 compared to a profit of €0.8 million in the corresponding half last year. The majority of the loss is attributed to an increase in financing expenses due to the linkage of the debt to the Israeli consumer price index. In addition, a regulatory change that increased the fines for deviating from the production plan requires Dorad to exercise caution in assessing the demand of existing customers, thereby reducing payments from the Israel Electric Company. Moreover, the majority of Dorad's profit is derived during July and August, and this is expected to be the case this year as well.

The total operating expenses of the various projects were 4.5% lower than forecast.

Projects under Construction

Pumped Storage Project in the Manara Cliff, Israel: The construction of the project is progressing as planned. Excavation of the main access tunnel is expected to begin in the coming days and extensive earthworks are being carried out in the area of the upper and lower reservoirs and in the area designated for the transformation station.

Ellomay Solar 28 MW PV Project in Spain: Construction work began a few months ago and is progressing as planned. The connection to the grid is expected at the end of 2021.

Projects under Development

Advanced Stage Development of 450 MW PV in Italy: The development of the projects is progressing as planned, a tender is currently being completed for contractors to carry out the first 3 projects with a total capacity of approximately 120 MW. The current estimate for the commencement of construction is the first quarter of 2022. In parallel, the licensing process of the remainder of the portfolio continues, which is expected to mature in 2022 and 2023 (the price of a quality license ready for construction in Italy is more than €200,000 per MW).

Initial Stage Development of 800 MW PV in Italy and Spain: the development of these projects continues.

Development of PV plus Storage PV Projects in Israel: land contracts have been executed and the projects are in licensing process with the relevant regulatory authorities.

Financing Expenses

The financing expenses item includes for the first time the financing expenses of the Talasol PV Plant in the amount of approximately €3.3 million (including the cost of an interest swap transaction in the amount of €0.6 million and interest on the shareholders' loan of the minority shareholders in the amount of €0.9 million (a non-cash expenses that creates a tax shield for the project). The financing expenses item also includes a one-time expense of approximately €0.8 million on early redemption of the Series B Debentures, which is expected to be returned to the Company through the interest savings achieved in the transition to Series C Debentures).

The financing expenses of the Company in connection with Debentures (excluding expenses in connection with the early repayment of Series B Debentures) were approximately €1.9 million.

Adjusted EBITDA and Adjusted FFO

The Adjusted EBITDA for the six month period ended June 30, 2021 was €13 million and the Adjusted FFO for the six month period ended June 30, 2021 was €9.6 million.

Use of NON-IFRS Financial Measures

EBITDA, Adjusted EBITDA and Adjusted FFO are non-IFRS measures. EBITDA is defined as earnings before financial expenses, net, taxes, depreciation and amortization and Adjusted FFO is calculated by deducting interest expenses on bank loans and debentures from the Adjusted EBITDA. The Company uses the terms "Adjusted EBITDA" and "Adjusted FFO" to highlight the fact that in the calculation of these Non-IFRS financial measures the Company presents the revenues from the Talmei Yosef PV Plant under the fixed asset model and not under IFRIC 12, presents its share in Dorad based on distributions of profit and not on the basis of equity gain using the equity method and includes the financial results of the Talasol PV Plant for the period prior to achievement of PAC that were not recognized in the profit and loss statement based on accounting rules. The Company presents these measures in order to enhance the understanding of the Company's operating performance and to enable comparability between periods. While the Company considers these non-IFRS measures to be important measures of comparative operating performance, these non-IFRS measures should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. These non-IFRS measures do not take into account the Company's commitments, including capital expenditures and restricted cash and, accordingly, are not necessarily indicative of amounts that may be available for discretionary uses. In addition, Adjusted FFO does not represent and is not an alternative to cash flow from operations as defined by IFRS and is not an indication of cash available to fund all cash flow needs, including the ability to make distributions. Not all companies calculate EBITDA, Adjusted EBITDA or Adjusted FFO in the same manner, and the measures as presented may not be comparable to similarly-titled measures presented by other companies. The Company's EBITDA, Adjusted EBITDA and Adjusted FFO may not be indicative of the Company's historic operating results; nor is it meant to be predictive of potential future results. The Company uses these measures internally as performance measures and believes that when these measures are combined with IFRS measures they add useful information concerning the Company's operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 13 of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

  • Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9MW in Israel;
  • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel's total current electricity consumption;
  • 51% of Talasol, which owns a photovoltaic plant with installed capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
  • Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;
  • 83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and delays, technical and other disruptions in the operations or construction of the power plants owned by the Company or in the development efforts of the projects under development by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: kaliaw@ellomay.com


 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position




June 30,

December 31,

June 30,



2021

2020

2021



(Unaudited)

(Audited)

(Unaudited)





Convenience Translation



€ in thousands

into US$ in thousands*

Assets





Current assets





Cash and cash equivalents


67,259

66,845

79,943

Marketable securities


-

1,761

-

Short term deposits


-

8,113

-

Restricted cash


4,216

-

5,011

Receivable from concession project


1,589

1,491

1,889

Trade and other receivables


9,761

9,825

11,62



82,825

88,035

98,445

Non-current assets





Investment in equity accounted investee


30,126

32,234

35,807

Advances on account of investments


2,445

2,423

2,906

Receivable from concession project


25,014

25,036

29,731

Fixed assets


312,983

264,095

372,008

Right-of-use asset


22,944

17,209

27,271

Intangible asset


4,506

4,604

5,356

Restricted cash and deposits


6,023

9,931

7,159

Deferred tax


5,785

3,605

6,876

Long term receivables


861

2,762

1,023

Derivatives


2,276

10,238

2,705



412,963

372,137

490,842

Total assets


495,788

460,172

589,287

Liabilities and Equity





Current liabilities





Current maturities of long term bank loans


13,204

10,232

15,694

Current maturities of long term loans


3,549

4,021

4,218

Debentures


12,815

10,600

15,232

Lease liability short term


8,288

** 490

9,851

Trade payables


2,692

12,387

3,202

Other payables


11,461

** 7,422

13,617



52,009

45,152

61,814

Non-current liabilities





Lease liability


15,524

17,299

18,452

Liabilities to banks


149,789

134,520

178,038

Other long-term loans


51,871

49,396

61,653

Debentures


80,661

72,124

95,873

Deferred tax


8,124

7,806

9,656

Other long-term liabilities


4,512

513

5,363

Derivatives


6,297

8,336

7,485



316,778

289,994

376,520

Total liabilities


368,787

335,146

438,334






Equity





Share capital


25,578

25,102

30,402

Share premium


85,762

82,401

101,936

Treasury shares


(1,736)

(1,736)

(2,063)

Transaction reserve with non-controlling Interests


5,145

6,106

6,115

Reserves


2,400

4,164

2,853

Retained earnings


2,613

8,191

3,106

Total equity attributed to shareholders of the Company


119,762

124,228

142,349

Non-Controlling Interest


7,239

798

8,604

Total equity


127,001

125,026

150,953

Total liabilities and equity


495,788

460,172

589,287

 

* Convenience translation into US$ (exchange rate as at June 30, 2021: EUR 1 = US$ 1.189)

** Reclassified

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (in thousands, except per share data)



For the three months
ended  June 30,

For the six months
ended June 30

For the year ended
December 31,

For the six months
ended June 30,


2021

2020

2021

2020

2020

2021


Unaudited

Unaudited

Audited

Unaudited


 

 

in thousands

 

 

in thousands

 

 

in thousands

Convenience Translation into US$*

Revenues

12,255

2,271

19,455

4,214

9,645

23,124

Operating expenses

(4,289)

(1,085)

(7,506)

(2,146)

(4,951)

(8,922)

Depreciation and amortization expenses

(4,005)

(721)

(7,056)

(1,447)

(2,975)

(8,387)

Gross profit

3,961

465

4,893

621

1,719

5,815








Project development costs

(614)

(584)

(1,119)

(2,338)

(3,491)

(1,330)

General and administrative expenses

(1,309)

(1,123)

(2,572)

(2,204)

(4,512)

(3,057)

Share of profits (losses) of equity accounted investee

(1,389)

(481)

(772)

850

1,525

(918)

Other income

-

-

-

-

2,100

-

Operating profit (loss)

649

(1,723)

430

(3,071)

(2,659)

510








Financing income

850

378

1,716

886

2,134

2,040

Financing income (expenses) in connection with derivatives and
  warrants, net

15

145

(109)

1,099

1,094

(130)

Financing expenses

(3,680)

(1,220)

(6,806)

(3,095)

(6,862)

(8,090)

Interest expenses on minority shareholder loan

(557)

-

(939)

-

-

(1,116)

Financing expenses, net

(3,372)

(697)

(6,138)

(1,110)

(3,634)

(7,296)

Loss before taxes on income

(2,723)

(2,420)

(5,708)

(4,181)

(6,293)

(6,786)

Tax benefit (Taxes on income)

(412)

16

(93)

(88)

125

(111)

Loss for the period

(3,135)

(2,404)

(5,801)

(4,269)

(6,168)

(6,897)

Loss attributable to:







Owners of the Company

(3,509)

(2,055)

(5,578)

(3,472)

(4,627)

(6,630)

Non-controlling interests

374

(349)

(223)

(797)

(1,541)

(267)

Loss for the period

(3,135)

(2,404)

(5,801)

(4,269)

(6,168)

(6,897)

Other comprehensive income (loss) items that







after initial recognition in comprehensive  income







 (loss) were or will be transferred to profit or loss:







Foreign currency translation differences for foreign
  operations

1,122

113

1,684

(86)

(482)

2,002

Effective portion of change in fair value of cash flow
  hedges

(3,273)

(23,401)

(5,202)

(9,289)

2,210

(6,183)

Net change in fair value of cash flow hedges

transferred to profit or loss

(221)

87

(1,225)

190

555

(1,456)

Total other comprehensive income (loss)

(2,372)

(23,201)

(4,743)

(9,185)

2,283

(5,637)








Total other comprehensive income (loss)
attributable to:







Owners of the Company

(652)

(11,638)

(1,764)

(4,737)

881

(2,096)

Non-controlling interests

(1,720)

(11,563)

(2,979)

(4,448)

1,402

(3,541)

Total other comprehensive income (loss)

(2,372)

(23,201)

(4,743)

(9,185)

2,283

(5,637)








Total comprehensive loss for the period

(5,507)

(25,605)

(10,544)

(13,454)

(3,885)

(12,534)








Total comprehensiveloss for the period
attributable to:







Owners of the Company

(4,161)

(13,693)

(7,342)

(8,209)

(3,746)

(8,726)

Non-controlling interests

(1,346)

(11,912)

(3,202)

(5,245)

(139)

(3,808)

Total comprehensiveloss for the period

(5,507)

(25,605)

(10,544)

(13,454)

(3,885)

(12,534)








Basic net loss per share

(0.28)

(0.17)

(0.44)

(0.29)

(0.38)

(0.52)

Diluted net loss per share

(0.28)

(0.17)

(0.44)

(0.29)

(0.38)

(0.52)

* Convenience translation into US$ (exchange rate as at June 30, 2021: EUR 1 = US$ 1.189)

 

Ellomay Capital Ltd. and its Subsidiaries  

Condensed Consolidated Interim Statements of Changes in Equity (in thousands)  




Attributable to shareholders of the Company

Non-
controlling

Total




Interests

Equity


 

 

 

Share
capital

 

 

 

Share
premium

 

 

 

Retained
earnings

 

 

 

Treasury
shares

 

Translation
reserve from
foreign
operations

 

 

 

Hedging
Reserve

Interests
Transaction
reserve with
non-controlling
Interests

 

 

 

Total




in thousands

For the six months ended June 30, 2021 (unaudited):











Balance as at January 1, 2021

25,102

82,401

8,191

(1,736)

3,823

341

6,106

124,228

798

125,026

Loss for the period

-

-

(5,578)

-

-

-

-

(5,578)

(223)

(5,801)

Other comprehensive loss for the period

-

-

-

-

1,636

(3,400)

-

(1,764)

(2,979)

(4,743)

Total comprehensive loss for the period

-

-

(5,578)

-

1,636

(3,400)

-

(7,342)

(3,202)

(10,544)

Transactions with owners of the Company,  recognized directly in equity:











Issuance of Capital note to non-controlling interest 

-

-

-

-

-

-

-

-

8,682

8,682

Acquisition of shares in subsidiaries from non-controlling interests 

-

-

-

-

-

-

(961)

(961)

961

-

Warrants exercise

454

3,348

-

-

-

-

-

3,802

-

3,802

Options exercise

22

-

-

-

-

-

-

22

-

22

Share-based payments

-

13

-

-

-

-

-

13

-

13

 Balance as at June 30, 2021

25,578

85,762

2,613

(1,736)

5,459

(3,059)

5,145

119,762

7,239

127,001

 

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)





Attributable to shareholders of the Company

Non-
controlling

Total




Interests

Equity


 

 

 

Share
capital

 

 

 

Share
premium

 

 

 

Retained
earnings

 

 

 

Treasury
shares

 

Translation
reserve from
foreign operations

 

 

 

Hedging
Reserve

Interests
Transaction
reserve with
non-controlling
Interests

 

 

 

Total




in thousands

For the six months ended June 30, 2020 (unaudited):











Balance as at January 1, 2020

21,998

64,160

12,818

(1,736)

4,356

(1,073)

6,106

106,629

937

107,566

Loss for the period

-

-

(3,472)

-

-

-

-

(3,472)

(797)

(4,269)

Other comprehensive loss for the period

-

-

-

-

(98)

(4,639)

-

(4,737)

(4,448)

(9,185)

Total comprehensive loss for the period

-

-

(3,472)

-

(98)

(4,639)

-

(8,209)

(5,245)

(13,454)

Transactions with owners of the Company,  recognized
 directly in equity:











Issuance of ordinary shares

1,935

11,253

-

-

-

-

-

13,188

-

13,188

Share-based payments

-

20

-

-

-

-

-

20

-

20

 Balance as at June 30, 2020

23,933

75,433

9,346

(1,736)

4,258

(5,712)

6,106

111,628

(4,308)

107,320

 

Ellomay Capital Ltd. and its Subsidiaries

 Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd)




Non-




controlling

Total


Attributable to shareholders of the Company

Interests

Equity

















Translation


Transaction





 

Share

 

Share

 

Retained

 

Treasury

Reserve from

foreign

 

Hedging

reserve with

non-controlling





capital

premium

earnings

shares

operations

Reserve

Interests

Total




in thousands

For the year ended  December 31, 2020 (audited):











Balance as at January 1, 2020

21,998

64,160

12,818

(1,736)

4,356

(1,073)

6,106

106,629

937

107,566

Profit (loss) for the year

-

-

(4,627)

-

-

-

-

(4,627)

(1,541)

(6,168)

Other comprehensive loss for the year

-

-

-

-

(533)

1,414

-

881

1,402

2,283

Total comprehensive loss for the year

-

-

(4,627)

-

(533)

1,414

-

(3,746)

(139)

(3,885)

Transactions with owners of the Company,
   recognized directly in equity:











Issuance of ordinary shares

3,084

18,191

-

-

-

-

-

21,275

-

21,275

Options exercise

20

-

-

-

-

-

-

20

-

20

Share-based payments

-

50

-

-

-

-

-

50

-

50

Balance as at











 December 31, 2020

25,102

82,401

8,191

(1,736)

3,823

341

6,106

124,228

798

125,026

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Interim Statements of Changes in Equity (in thousands) (cont'd) 





Attributable to shareholders of the Company

Non-
controlling

Total




Interests

Equity


 

 

 

Share
capital

 

 

 

Share
premium

 

 

 

Retained
earnings

 

 

 

Treasury
shares

 

Translation
reserve from

foreign
operations

 

 

 

Hedging
Reserve

Interests
Transaction
reserve with

non-controlling
Interests

 

 

 

Total




Convenience translation into US$*

For the six months ended June 30, 2021 (unaudited):











Balance as at January 1, 2021

29,836

97,942

9,736

(2,063)

4,544

405

7,257

147,657

951

148,608

Loss for the period

-

-

(6,630)

-

-

-

-

(6,630)

(267)

(6,897)

Other comprehensive loss for the period

-

-

-

-

1,945

(4,041)

-

(2,096)

(3,541)

(5,637)

Total comprehensive loss for the period

-

-

(6,630)

-

1,945

(4,041)

-

(8,726)

(3,808)

(12,534)

Transactions with owners of the Company, 
 recognized directly in equity:











Issuance of Capital note to non-controlling interest 

-

-

-

-

-

-

-

-

10,319

10,319

Buy of shares in subsidiaries from non-controlling
  interests

-

-

-

-

-

-

(1,142)

(1,142)

1,142

-

Warrants exercise

540

3,979

-

-

-

-

-

4,519

-

4,519

Options exercise

26

-

-

-

-

-

-

26

-

26

Share-based payments

-

15

-

-

-

-

-

15

-

15

 Balance as at June 30, 2021

30,402

101,936

3,106

(2,063)

6,489

(3,636)

6,115

142,349

8,604

150,953

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Unaudited Interim Statements of Cash Flows



For the three months
ended June 30
,

For the six months
ended June 30
,

For the year ended
December 31,

For the six months
ended June 30


2021

2020

2021

2020

2020

2021


Unaudited

Unaudited

Audited

Unaudited


 

 

in thousands

Convenience
Translation into
US$*

Cash flows from operating activities







Profit for the period

(3,135)

(2,404)

(5,801)

(4,269)

(6,168)

(6,897)

Adjustments for:







Financing expenses, net

3,372

697

6,138

1,110

3,634

7,296

Profit from settlement of derivatives contract

-

-

(407)

-

-

(484)

Depreciation and amortization

4,005

721

7,056

1,447

2,975

8,387

Share-based payment transactions

6

6

13

20

50

15

Share of losses (profits) of equity accounted investee

1,389

481

772

(850)

(1,525)

918

Payment of interest on loan from an equity accounted investee

859

-

859

582

582

1,021

Change in trade receivables and other receivables

(942)

(461)

(2,124)

127

(3,868)

(2,525)

Change in other assets

(812)

(19)

(782)

(234)

179

(929)

Change in receivables from concessions project

536

503

757

704

1,426

900

Change in trade payables

(559)

(350)

(941)

(35)

190

(1,118)

Change in other payables

2,119

642

3,715

368

(1,226)

4,416

Income tax expense (tax benefit)

412

(16)

93

88

(125)

111

Income taxes paid

(15)

-

(15)

-

(119)

(18)

Interest received

494

428

921

869

2,075

1,095

Interest paid

(2,651)

(1,685)

(3,857)

(1,853)

(3,906)

(4,584)

Net cash from (used in) operating activities

5,078

(1,457)

6,397

(1,926)

(5,826)

7,604

Cash flows from investing activities







Acquisition of fixed assets

(38,140)

(39,866)

(63,793)

(81,280)

(128,420)

(75,824)

Acquisition of subsidiary, net of cash acquired

-

-

-

-

(7,464)

-

Repayment of loan by an equity accounted investee

1,400

-

1,400

1,923

1,978

1,664

Loan to an equity accounted investee

(131)

-

(244)

-

(181)

(290)

Advances on account of investments

(8)

-

(8)

-

(1,554)

(10)

Settlement of derivatives contract

-

-

(252)

-

-

(300)

Proceeds (investment) in restricted cash, net

(639)

(5)

(185)

22,580

23,092

(220)

Proceeds (investment) in short term deposit

-

-

8,533

-

(1,323)

10,142

Proceeds from marketable securities

-

-

1,785

-

1,800

2,122

Acquisition of marketable securities

-

(5)

-

-

(1,481)

-

Compensation as per agreement with Erez Electricity Ltd

-

1,418

-

1,418

1,418

-

Net cash used in investing activities

(37,518)

(38,453)

(52,764)

(55,359)

(112,135)

(62,716)

Cash flows from financing activities







Sale of shares in subsidiaries to non-controlling interests

-

-

1,400

-

-

1,664

Proceeds from options

-

-

22

-

20

26

Cost associated with long term loans

-

-

(197)

-

(734)

(234)

Proceeds from long term loans

5,415

39,661

32,476

80,584

111,357

38,601

Repayment of long-term loans

(2,933)

(1,994)

(3,390)

(2,804)

(3,959)

(4,029)

Repayment of Debentures

(8,853)

(4,761)

(30,730)

(26,923)

(26,923)

(36,525)

Issuance of ordinary shares

-

-

-

13,188

21,275

-

Proceeds from issue of convertible debentures

-

-

15,571

-

-

18,508

Proceeds from issuance of Debentures, net

-

-

25,465

-

38,057

30,267

Issuance / exercise of warrants

-

-

3,675

320

2,544

4,368

Net cash from (used in) financing activities

(6,371)

32,906

44,292

64,365

141,637

52,646








Effect of exchange rate fluctuations on cash and cash equivalents

1,050

471

2,489

(357)

(1,340)

2,958

Increase (decrease) in cash and cash equivalents

(37,761)

(6,533)

414

6,723

22,336

492

Cash and cash equivalents at the beginning of the period

105,020

57,765

66,845

44,509

44,509

79,451

Cash and cash equivalents at the end of the period

67,259

51,232

67,259

51,232

66,845

79,943

 

* Convenience translation into US$ (exchange rate as at June 30, 2021: EUR 1 = US$ 1.189)


                                  

 

 

Ellomay Capital Ltd. and its Subsidiaries

Operating Segments



PV




Total






Ellomay



Bio



reportable


Total


Italy

Spain

Solar[3]

Talasol

Israel[1]

Gas

Dorad

Manara

segments

Reconciliations

consolidated


For the six months ended June 30, 2021


€ in thousands













Revenues

-

1,534

-

11,202[2]

2,130

6,129

22,940

-

43,935

(24,480)

19,455

Operating expenses

-

(423)

-

(1,988)

(170)

(4,925)

(18,049)

-

(25,555)

18,049

(7,506)

Depreciation expenses

-

(451)

-

(4,816)

(1,151)

(1,552)

(2,685)

-

(10,655)

3,599

(7,056)

Gross profit (loss)

-

660

-

4,398

809

(348)

2,206

-

7,725

(2,832)

4,893

Project development costs











(1,119)

General and












 administrative expenses











(2,572)

Share of loss of equity












accounted investee











(772)

Operating profit











430

Financing income











1,716

Financing expense in connection












 with derivatives and warrants, net











(109)

Financing expenses, net











(7,745)

Loss before taxes












 on Income











(5,708)

Segment assets as at












 June 30, 2021

833

15,130

5,589

242,224

35,548

34,903

106,164

90,300

530,691

(34,904)

495,787

 

 

[1] The Talmei Yosef PV Plant located in Israel is presented under the fixed asset model and not under the financial asset model as per IFRIC 12.

[2] Not including an amount of approximately €1 million of proceeds from the sale of electricity prior to January 27, 2021 (the date in which the Talasol PV Plant achieved PAC).

[3] Ellomay Solar, S.L, the developer of a 28 MW solar project near the Talasol PV Plant.

 

 

 

Ellomay Capital Ltd. and its Subsidiaries

Reconciliation of Loss to EBITDA (in thousands)



For the three months
ended June 30,

For the six months
ended June 30,

For the year ended
December 31,

For the six months
ended June 30,


2021

2020

2021

2020

2020

2021


Unaudited


 

 

in thousands

Convenience
Translation
into US$*

Loss for the period

(3,135)

(2,694)

(5,801)

(4,269)

(6,168)

(6,897)

Financing expenses, net

3,372

782

6,138

1,110

3,634

7,296

Taxes on income

412

(18)

93

88

(125)

111

Depreciation

4,005

808

7,056

1,447

2,975

8,387

EBITDA

4,654

(1,122)

7,486

(1,624)

316

8,897

 

* Convenience translation into US$ (exchange rate as at June 30, 2021: EUR 1 = US$ 1.189)

 

Reconciliation of Loss to Adjusted EBITDA and to Adjusted FFO  


For the six months ended June 30, 2021


Unaudited


in thousands

Loss for the period

(5,801)

Financing expenses, net

6,138

Taxes on income

93

Depreciation

7,056

Adjustment to the Share of loss of equity accounted investee to include the Company's share in distributions 

3,031

Adjustment to the revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model

1,540

Adjustment to include the financial revenues of the Talasol PV Plant for the period prior to achievement of PAC that were not recognized in the profit and loss statement based on accounting rules

895

Adjusted EBITDA

12,952

Interest expenses on bank loans and debentures

(3,405)

Adjusted FFO

9,547





 

Information for the Company's Debenture Holders

Pursuant to the Deeds of Trust governing the Company's Series C and Series D Debentures (together, the "Debentures"), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company's Annual Report on Form 20-F submitted to the Securities and Exchange Commission on March 31, 2021 and below.

 Net Financial Debt

As of June 30, 2021, the Company's Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company's Debentures), was approximately €28.6 million (consisting of approximately €237.9[3] million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €95.9[4] million in connection with the Series C Debentures issuances (in July 2019,  October 2020 and February 2021) and Series D Debentures issuance (in February 2021), net of approximately €67.3 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €237.9[5] million of project finance and related hedging transactions of the Company's subsidiaries).

[3] Short-term and long-term debt from banks and other interest bearing financial obligations amount provided above, includes an amount of approximately €11.7 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company's balance sheet. 

[4] Debentures amount provided above, includes an amount of approximately €2.4 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company's balance sheet. 

[5] The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders' loans to the project companies).

Information for the Company's Series C Debenture Holders.

The Deed of Trust governing the Company's Series C Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of June 30, 2021, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company's shareholders' equity was approximately €127 million (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) was 18.4%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA[6], was 2.3. 

The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended June 30, 2021:

 


For the four quarter period
ended June 30, 2021


Unaudited


in thousands

Loss for the period

(7,700)

Financing expenses, net

8,662

Taxes on income

(120)

Depreciation

8,584

Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model

3,039

Share-based payments

43

Adjusted EBITDA as defined the Series C Deed of Trust

12,508

 

[6] The term "Adjusted EBITDA" is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."


 

Information for the Company's Series D Debenture Holders

The Deed of Trust governing the Company's Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of June 30, 2021, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company's Adjusted Shareholders' Equity (as defined in the Series D Deed of Trust) was approximately €126.6 million (ii) the ratio of the Company's Net Financial Debt (as set forth above) to the Company's CAP, Net (defined as the Company's consolidated shareholders' equity plus the Net Financial Debt) was 18.4%, and (iii) the ratio of the Company's Net Financial Debt to the Company's Adjusted EBITDA[7] was 1.2. 

The following is a reconciliation between the Company's loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended June 30, 2021: 

 


For the four quarter period
ended June 30, 2021


Unaudited


in thousands

Loss for the period

(7,700)

Financing expenses, net

8,662

Taxes on income

(120)

Depreciation

8,584

Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model

3,039

Share-based payments

43

Adjustment to data relating to projects with a Commercial Operation Date during the four preceding quarters[8]

10,457

Adjusted EBITDA as defined the Series D Deed of Trust

22,965

 

[7] The term "Adjusted EBITDA" is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company's operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company's undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under "Use of NON-IFRS Financial Measures."

 

[8] The adjustment is based on the results of the Talasol Project since January 27, 2021 and of the biogas plant in Gelderland since January 1, 2021. The results of the biogas plant in Gelderland were not included in the profit and loss statement of the Company for the year ended December 31, 2020.

Cision View original content:https://www.prnewswire.com/news-releases/ellomay-capital-reports-results-for-the-three-and-six-months-ended-june-30-2021-301389362.html

SOURCE Ellomay Capital Ltd